BARBANENTE, ALESSANDRA

BARBANENTE, ALESSANDRA  

Mostra records
Risultati 1 - 11 di 11 (tempo di esecuzione: 0.12 secondi).
Titolo Data di pubblicazione Autore(i) File
Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1R,2R and 1S,2S enantiomers of the trans-1,2-diamino-4-cyclohexene ligand (DACHEX), an analogue of diaminocyclohexane used in oxaliplatin 1-gen-2021 Papadia, Paride; Barbanente, Alessandra; Ditaranto, Nicoletta; Hoeschele, James D; Natile, Giovanni; Marzano, Cristina; Gandin, Valentina; Margiotta, Nicola
Interaction of Copper Trafficking Proteins with the Platinum Anticancer Drug Kiteplatin 1-gen-2022 Barbanente, A.; Galliani, A.; Iacobazzi, R. M.; Lasorsa, A.; Nardella, M. I.; Pennetta, A.; Margiotta, N.; Arnesano, F.
A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ring 1-gen-2019 Papadia, Paride; Gandin, Valentina; Barbanente, Alessandra; Ruello, Alessandro G.; Marzano, Cristina; Micoli, Katia; Hoeschele, James D.; Natile, Giovanni; Margiotta, Nicola
New Oxaliplatin-Pyrophosphato Analogs with Improved In Vitro Cytotoxicity 1-gen-2021 Barbanente, Alessandra; Maria Iacobazzi, Rosa; Azzariti, Amalia; Hoeschele, James D.; Denora, Nunzio; Papadia, Paride; Pacifico, Concetta; Natile, Giovanni; Margiotta, Nicola
One-Pot Synthesis of New Organometallic Compounds with Platinum-Carbon Bond 1-gen-2020 Barbanente, A.; Margiotta, N.; Pacifico, C.; Intini, F. P.; Natile, G.
Platinum(IV) complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs affording an oxaliplatin analogue that overcomes cancer resistance 1-gen-2020 Papadia, P.; Micoli, K.; Barbanente, A.; Ditaranto, N.; Hoeschele, J. D.; Natile, G.; Marzano, C.; Gandin, V.; Margiotta, N.
Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells 1-gen-2020 Barbanente, A.; Nadar, R. A.; Esposti, L. D.; Palazzo, B.; Iafisco, M.; Van Den Beucken, J. J. J. P.; Leeuwenburgh, S. C. G.; Margiotta, N.
Preclinical evaluation of platinum-loaded hydroxyapatite nanoparticles in an embryonic zebrafish xenograft model 1-gen-2020 Nadar, R. A.; Asokan, N.; Degli Esposti, L.; Curci, A.; Barbanente, A.; Schlatt, L.; Karst, U.; Iafisco, M.; Margiotta, N.; Brand, M.; Van Den Beucken, J. J. J. P.; Bornhauser, M.; Leeuwenburgh, S. C. G.
Pt(IV) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity 1-gen-2021 Gabano, Elisabetta; Rangone, Beatrice; Perin, Elena; Caron, Giulia; Ermondi, Giuseppe; Vallaro, Maura; Gandin, Valentina; Marzano, Cristina; Barbanente, Alessandra; Margiotta, Nicola; Ravera, Mauro
A Pt(IV) prodrug of kiteplatin with the bone-targeting pyrophosphate ligand 1-gen-2019 Barbanente, Alessandra; Gandin, Valentina; Ditaranto, Nicoletta; Marzano, Cristina; Hoeschele, James D.; Suranna, Gian Paolo; Papadia, Paride; Natile, Giovanni; Margiotta, Nicola
Selenium-doped hydroxyapatite nanoparticles for potential application in bone tumor therapy 1-gen-2021 Barbanente, A.; Palazzo, B.; Esposti, L. D.; Adamiano, A.; Iafisco, M.; Ditaranto, N.; Migoni, D.; Gervaso, F.; Nadar, R.; Ivanchenko, P.; Leeuwenburgh, S.; Margiotta, N.